我国临床科研机构标本保护的探讨

Discussion on biological samples collection and protect in clinical research institutes in China

临床科研机构人体科研标本的收集和保护,是临床生物技术发展的基础。借鉴美国医疗科研机构收集和保存标本的做法,利于我国临床科研机构知识产权的保护。

The Catalona case has important implications for any institution collecting and maintaining biological samples and clinical data, and for an institution relying upon biological samples and clinical data for research activities in Chinese hospital. Intellectual property policy, informed consent, authorization and scope of the research program should be studied by Chinese hospitals.